Abcellera Biologics INC. (ABCL) — DEF 14A Filings
All DEF 14A filings from Abcellera Biologics INC.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
AbCellera Biologics Inc. Files 2024 DEF 14A
— Apr 29, 2025 Risk: low
AbCellera Biologics Inc. filed its DEF 14A on April 29, 2025, for the fiscal year ending December 31, 2024. The filing provides details on executive compensatio -
AbCellera Biologics Inc. Files Definitive Proxy Statement
— Apr 29, 2024 Risk:
AbCellera Biologics Inc. (ABCL) filed a Proxy Statement (DEF 14A) with the SEC on April 29, 2024. AbCellera Biologics Inc. filed a Definitive Proxy Statement (D
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX